Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on December 25, 2007
JNCI Journal of the National Cancer Institute 2008 100(1):1; doi:10.1093/jnci/djm321
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/1/1-a    most recent
djm321v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

MEMO TO THE MEDIA

Anthracyclines Improve Survival in HER2-Positive Breast Cancer Patients

Liz Savage, Andrea Widener

jncimedia@oxfordjournals.org
301-841-1287

The first 10% of the full text of this article appears below.

Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online December 25 in the Journal of the National Cancer Institute.

Randomized clinical trials . . . [Full Text of this Article]

Contact:

Citation:

Note to Reporters:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, Matteo Puntoni, Mariantonietta Colozza, Ulrich Pfeffer, and Paolo Bruzzi
J Natl Cancer Inst 2008 100: 14-20. [Abstract] [Full Text] [PDF]

Anthracyclines in the Treatment of HER2-Negative Breast Cancer
Soonmyung Paik, Yusuke Taniyama, and Charles E. Geyer, Jr
J Natl Cancer Inst 2008 100: 2-4. [Extract] [Full Text] [PDF]